Cargando…
The Recurrent Vulvovaginal Candidiasis: Proposal of a Personalized Therapeutic Protocol
Background. Recurrent vulvovaginal candidiasis (RVC) is an increasing challenge in clinical practice. Objective. The purpose of this study was to reduce the episodes of RVC through the intake of fluconazole 200 mg/dose with a personalized regimen at growing administration intervals with a probiotic....
Autores principales: | Murina, F., Graziottin, A., Felice, R., Radici, G. L., Di Francesco, S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scholarly Research Network
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3153925/ https://www.ncbi.nlm.nih.gov/pubmed/21845227 http://dx.doi.org/10.5402/2011/806065 |
Ejemplares similares
-
Distinct host immune responses in recurrent vulvovaginal candidiasis and vulvovaginal candidiasis
por: Ge, Gai, et al.
Publicado: (2022) -
Recurrent Vulvovaginal Candidiasis: An Immunological Perspective
por: Rosati, Diletta, et al.
Publicado: (2020) -
Treatment of Recurrent Vulvovaginal Candidiasis With Ibrexafungerp
por: Grant, Leah M., et al.
Publicado: (2022) -
Insights and advances in recurrent vulvovaginal candidiasis
por: San Juan Galán, Javier, et al.
Publicado: (2023) -
Clinical challenges in diagnosis and treatment of recurrent
vulvovaginal candidiasis
por: Neal, Chemen M, et al.
Publicado: (2022)